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The increase in intra-abdominal pressure (IAP) above specific levels (i.e., intra-abdominal
hypertension, IAH) may lead to organ dysfunction in abdominal and extra-abdominal systems
(Kirkpatrick and Roberts, 2013). Possible etiologies or risk factors for IAH development
comprehend diminished abdominal compliance, increased intraluminal or intra-abdominal
contents and capillary leak/fluid resuscitation (Kirkpatrick and Roberts, 2013). In this conditions,
formally known as abdominal compartment syndrome, acute kidney injury (AKI) frequently
develops and further worsens the patients outcome (Dalfino et al., 2008).
Pathophysiological mechanisms leading to AKI during IAH are not completely known;
nevertheless, evidence from the literature recognize the decrease in renal perfusion as the main
factor responsible for development of AKI in this condition (De Waele et al., 2011). In particular,
renal hypoperfusion might occur during an acute or progressive increase in IAP, mainly due to
the reduction of both arterial inflow and venous outflow, leading to glomerular hemodynamic
alterations.
Beyond the subsequent activation of neuro-hormonal pathways (e.g., noradrenergic response
and Renin-Angiotensin-Aldosteron system), the intrarenal hemodynamic alteration may be itself
the responsible for an acute decrease of glomerular filtration gradient (FG; De Waele et al., 2011).
The FG reflects the balance among hydrostatic and oncotic forces that support the ultrafiltration
through the glomerular barrier. During IAH, the decrease of glomerular hydrostatic pressure (due
to hypoperfusion) and the increase of Bowman’s space hydrostatic pressure (due to IAH) may lead
to acute reduction in FG (DeWaele et al., 2011). Data from literature confirm an inverse correlation
between IAP and FG (Harman et al., 1982).
Physiologically, an acute increase in IAP narrows renal arteries and veins, reduces renal blood
flow, leading to the activation of autoregulatory mechanisms. These cause a vasodilation of afferent
arterioles, ensuring glomerular filtration also during the early stage of acute increase in IAP (Just,
2007). Probably, the activation of these mechanismsmay determine an acute increase in glomerular
filtration during stressful events and we hypothesized that it might be related to the patient’s renal
functional reserve. Moreover, the same IAP value may produce different levels of decreased renal
function related to different levels of myogenic response influencing the efficiency of autoregulatory
mechanisms.
According to experimental data showed by Harman et al., Figure 1 represents the correlation
between current renal function (x axis) and IAP (y-right axis) (Harman et al., 1982). In patients
with effective myogenic response (patient n◦1, dashed line), an acute increase in IAP is associated
to a slight decrease in renal function. Whereas, in patients with a compromised myogenic response
(patient n◦2, solid line), and lower renal functional reserve, an acute increase in IAP is associated
with a strong reduction in renal function.
Villa et al. Kidney Damage during Intra-Abdominal Hypertension
FIGURE 1 | Correlation between current renal function, intra-abdominal pressure (IAP), and biomarkers of acute kidney injury (AKI). Patient n◦ 1
(dashed line): in presence of effective myogenic response, an acute increase in IAP is associated to a slight decrease in renal function (tract 0–C). A further increase of
IAP may lead to biomarkers increase (subclinical AKI, tract C–D). When IAP overcomes the intrarenal autoregulation, glomerular hypoperfusion occurs and a picture of
clinical AKI becomes manifest (above point D). Patient n◦ 2 (solid line): in presence of compromised myogenic response, an acute increase in IAP is associated with a
strong reduction in renal function until the development of clinical functional AKI (tract A–B). If IAP further increases, the inflammatory and ischemic insults may lead to
the kidney parenchymal damage detectable by biomarkers (above point B).
Although the hemodynamic issue is certainly quintessential
to explain the pathophysiology of AKI during IAH, other
mechanisms may further affect the kidney function (e.g., the
direct parenchyma compression or the inflammatory damage;
Doty et al., 2000; Kösüm et al., 2013).
Beyond the etiological conditions leading to the acute increase
in IAP, the IAH itself may induce systemic inflammation
(Rezende-Neto et al., 2002). Indeed, it is well known as systemic
inflammation can widely sustain AKI through circulating
biochemical factors inducing apoptotic/necrotic damages to the
renal parenchyma (Honore et al., 2011). Furthermore, also
metabolic alterations induced locally may be recognized in the
kidney during IAH. In particular, during IAP elevation a widely
range of genes are up- and down-regulated in the kidney,
leading to a dynamic and constantly changingmetabolic response
(Edil et al., 2003). In experimental models of IAH, high levels
of locally-produced inflammatory mediators (e.g., TNF-a or
IL-6) have been demonstrated in the kidney during the IAP
elevation as well as their association with histopathological and
cytoarchitectural alterations (Akbulut et al., 2010; Kösüm et al.,
2013).
The susceptibility to kidney damage due to hemodynamic or
biological insults during “IAH exposure” might be theoretical
detectable through the use of biomarkers of AKI (Li et al., 2014).
Several biomarkers have been proposed to identify the kidney
damage during clinical scenarios at risk for AKI, for example
the perioperative urinary liver-type fatty-acid-binding protein
during endovascular abdominal repair (Obata et al., 2016).
Although most of literature provides information on specific
molecules, such as neutrophil gelatinase-associated lipocalin
or Kidney injury molecule-1, biomarkers of cell-cycle arrest
have been recently identified as the most sensitive and specific
biomarkers for AKI in most clinical settings (Kashani et al.,
2013). According to ADQI classifications (McCullough et al.,
2013), biomarkers of AKI might identify the parenchyma
kidney damage occurred after a metabolic insult, whereas
the clinical classifications based on urinary output or serum
creatinine (aimed to quantify the glomerular filtration rate)
might identify the kidney dysfunction (Ronco et al., 2012). As
demonstrated in literature, clinical AKI is widely correlated
with an increased patients’ mortality; in these conditions the
use of biomarkers of kidney damage might inform about
severity, prognosis, and recovery from AKI (Endre et al., 2011).
Nevertheless, also conditions characterized by an increase of
biomarkers of kidney damage, but in which clinical scoring
systems fail to identify a kidney dysfunction (i.e., “subclinical
AKI”) are associated to patients’ mortality (Ronco et al.,
2012).
The identification of the pathophysiological mechanisms
for AKI, as well as the quantification of specific patient’s
responses to pathological stimuli (as myogenic activation and
renal functional reserve) and the evaluation of the kidney
damage/dysfunction, should be achieved during IAH-induced
AKI. This may allow a personalized treatment for that specific
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patient and a target-directed therapy for AKI (Joannidis et al.,
2010) even during IAH.
In particular, in patient n◦2 (with low myogenic response)
renal function rapidly falls during IAP elevation until the
development of clinical AKI (from point A). In this situation,
the ineffective response of the patient to the reduced glomerular
perfusion might produce a clinical “functional” AKI even if the
parenchymal kidney damage (biological or ischemic) does not
actually occurred (tract A–B). In this phase the optimization of
cardiac output and/or volume replacement might increase the
renal perfusion restoring glomerular function. If IAP further
increases, the biological inflammatory insult, as well as the
ischemic insult deriving from hypoperfusion, may lead to the
kidney parenchymal damage detectable by biomarkers (above
point B).
On the other hand, in patient n◦1 (with an effective myogenic
response) renal function slightly decreases during the IAP
elevation (from point 0 to C). The patient’s effective intrarenal
autoregulation allows him to maintain the glomerular filtration
pressure in this early phase, avoiding the “functional” AKI
(deriving from hypoperfusion or hypovolemia). However, the
progression of IAH and the subsequent biological inflammatory
insult may lead to kidney damage clinically detectable through
the biomarkers increase (point C). In this specific condition, the
reduction of renal function occurs in a picture of subclinical AKI
(from point C to D), in which the patient’s parenchymal damage
is associated to a normal glomerular function sustained by
intrarenal autoregulation. If IAH progresses, the IAP overcomes
the intrarenal autoregulation, glomerular hypoperfusion occurs
meanwhile the biological insult progresses and a picture of
clinical AKI becomes manifest (above point D).
In conclusion, although pathophysiological mechanisms
responsible to AKI during IAH are not completely understood,
the decrease in renal perfusion is one of the most important
causative factor (De Waele et al., 2011). The acute increase
of intra-abdominal pressure reduces the renal blood flow
and triggers the autoregulatory mechanisms, acutely rising
glomerular filtration. The integrity of myogenic response
might be related to the patient’s capability to maintain an
adequate glomerular filtration rate during stressful conditions
(e.g., metabolic load or hemodynamic insult leading to kidney
hypoperfusion). Other etiological stimuli such as inflammatory
end/or toxic exposures may also induce kidney impairment
and/or kidney dysfunction during IAH, thus leading to clinical
or subclinical AKI. In a comprehensive approach to the kidney
function during IAH, the evaluation of myogenic response
with the clinical and biochemical parameters of AKI may
have a role to personalizing the treatment for each specific
patient.
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